PanGenomic Health, Inc. Class A

As of June 30, 2026, PanGenomic Health, Inc. Class A carries a market capitalization of 9.51M, placing it among publicly traded companies globally. Its enterprise value stands at 10.22M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, PanGenomic Health, Inc. Class A has 25.70M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, PanGenomic Health, Inc. Class A maintains a current ratio of 0.05, meaning it holds 0.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -25.97, indicating conservative leverage, while an interest coverage ratio of -196.07 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended June 30, 2026. Return on assets (ROA) is negative at -4,309.33, reflecting losses generated across the asset base.

As of the close on October 9, 2026, PanGenomic Health, Inc. Class A's stock has declined approximately 92.56% over the past 52 weeks. The 50-day moving average sits at 0.34, while the 200-day moving average is 1.05.

Over the twelve months ended June 30, 2026, PanGenomic Health, Inc. Class A generated - - in revenue and converted that into -4.25M in net income, yielding earnings per share of -0.18. EBITDA reached -4.19M, while operating income came in at -4.04M.

As of June 30, 2026, PanGenomic Health, Inc. Class A holds 7,717.00 in cash and equivalents against 715,335.00 in total debt, resulting in a net debt position of 707,618.00. Total book value stands at -2.75M, with working capital of -2.76M providing operational flexibility.

PanGenomic Health, Inc. Class A produced -2.21M in operating cash flow over the twelve months ended June 30, 2026.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -25.86: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -23.28, meaning PanGenomic Health, Inc. Class A raised more capital through share issuance and new debt than it returned via dividends and buybacks.

PanGenomic Health, Inc. Class A's most recent stock split took place on November 14, 2024 with a 5:1 split ratio.

As of June 30, 2026, PanGenomic Health, Inc. Class A has an Altman Z-Score of -341.36, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.